ASX-Dividend-Report-Banner

Sky Labs' CART BP Becomes the World's First to Complete Comparative Studies with All Blood Pressure Measurement Methods

February 15, 2024 12:00 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Sky Labs' CART BP Becomes the World's First to Complete Comparative Studies with All Blood Pressure Measurement Methods
Image source: Kalkine Media

- The only cuffless blood pressure monitor to complete comparative studies with three types of existing blood pressure measurement methods and prove even accuracy

- 24-hour Ambulatory Blood Pressure Monitoring is the first pilot research to reflect ESH recommendations in 2023


SEOUL, South Korea, Feb. 14, 2024 /PRNewswire/ -- CART BP is a ring-type 24/7 blood pressure monitor of the global healthcare startup Sky Labs(CEO Jack, Lee), and has fully established itself as the only ring-type wearable medical device to complete comparative studies with all blood pressure measurement methods, becoming the first in the world.  

Ring-shaped CART BP and charger
Ring-shaped CART BP and charger

There are currently three main blood pressure measurement methods: auscultatory method in which a cuff-based blood pressure monitor and stethoscope are used in clinics to measure blood pressure; invasive blood pressure measurement method in which a needle or catheter is inserted into an artery (A-line) to measure intra-arterial pressure; and Ambulatory Blood Pressure Monitoring (ABPM) that measures blood pressure during a 24-hour period outside clinics by attaching a cuff and monitor to the body. To prove CART BP's effectiveness, Sky Labs completed all comparative studies with these three blood pressure measurement methods.    

Conducted at Seoul National University Hospital, the 24-hour ABPM comparative studies were the world's first clinical research to reflect the European Society of Hypertension(ESH)'s recommendations for the validation of cuffless blood pressure monitoring devices that were announced in June last year. Sky Labs explained the research's significance as announcing a preliminary result for the 'awake/asleep test,' which is the most difficult to validate from among the five tests presented by ESH. The research outcome was published in the Korean Circulation Journal (KCJ).

In addition, Sky Labs validated accuracy in comparative studies with the invasive arterial blood pressure measurement method and standard stethoscopy. The research outcome was respectively published in Nature Scientific Reports and Journal of Korean Medical Science (JKMS).  

CART BP is highly useful compared to other blood pressure monitors in that it enables 24-hour measurements of even blood pressure variability when an individual is asleep, not to mention awake. It can be conveniently worn without any disturbance to daily life and enables the use of a smart phone to check blood pressure, allowing individuals to monitor their respective blood pressure anytime, anywhere. In addition, it can detect white coat, masked, morning, and nocturnal hypertension, which are difficult to measure at hospitals, and is therefore expected to contribute to more accurate diagnoses by medical staff.

Sky Labs CEO Jack, Lee said, "I believe CART BP showed its potential to replace existing blood pressure monitors that cause considerable inconvenience in that it proved effectiveness in comparison to all three types of leading blood pressure monitors that are used in the global medical community. Our goal is to receive US FDA and Europe's CE approvals this year based on these research outcomes."


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.